New Delhi, Mar 5
The Competition Commission of India (CCI) has approved the proposed acquisition of a certain shareholding in Schott Poonawalla Private Limited (SPPL) by TPG Scion SG Pte. Ltd. The acquisition involves a secondary purchase of shares from Serum Institute of India Private Limited by TPG Scion.
TPG Scion SG Pte. Ltd., incorporated in Singapore on October 11, 2024, is a special purpose investment vehicle created specifically for this acquisition. It currently has no operations in India and is affiliated with the TPG Group, a global investment firm founded in 1992. The TPG Group, through its subsidiaries and affiliates, is ultimately managed and controlled by an entity advised by affiliates of TPG Inc., the group’s ultimate holding company.
Schott Poonawalla Private Limited (SPPL) specializes in the development, manufacturing, and sale of pharmaceutical glass packaging solutions, including ampoules, vials, cartridges, and prefilled syringes, made from tubular glass.
Further details on the CCI’s order will be released in due course.
(Source: PIB)
